Table 2.
Multivariable linear regressions for the associations between non-calcified coronary plaque burden and cardiovascular risk factors and psoriasis characterization
| Parameters | Non-calcified plaque burden (mm2) (n = 121) |
|---|---|
| Demographics and medical history | β (P-value) |
| Age (years) | 0.04 (0.40) |
| Males | 0.37 (<0.001) |
| Body mass index | 0.52 (<0.001) |
| Hypertension | 0.24 (<0.001) |
| Hyperlipidaemia | 0.10 (0.02) |
| Type-2 diabetes mellitus | 0.05 (0.19) |
| Current smoker | 0.10 (0.03) |
| Clinical and laboratory data | |
| Total cholesterol (mg/dL) | −0.05 (0.45) |
| HDL cholesterol (mg/dL) | −0.30 (<0.001) |
| LDL cholesterol (mg/dL) | −0.01 (0.72) |
| Framingham risk score | 0.29 (<0.001) |
| C-reactive protein | 0.11 (0.005) |
| HOMA-IR | 0.19 (<0.001) |
| Psoriasis characterization | |
| PASI score | 0.20 (<0.001) |
| Disease duration | 0.05 (0.24) |
All data in the table is expressed as standardized β (P-value). Two-tailed P-values less than 0.05 deemed significant (bold values).
HOMA-IR, homeostasis model assessment of insulin resistance; PASI, Psoriasis Area and Severity Index.